Overview

Raltegravir and Ezetimibe PK Study

Status:
Completed
Trial end date:
2008-08-01
Target enrollment:
Participant gender:
Summary
Evaluation of the pharmacokinetics and safety of raltegravir and ezetimibe when co-administered to male and female healthy volunteers.
Phase:
Phase 1
Details
Lead Sponsor:
St Stephens Aids Trust
Treatments:
Ezetimibe
Raltegravir Potassium